| 22.1 |
66.3 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 21.2 |
63.5 |
GO:0060466 |
activation of meiosis involved in egg activation(GO:0060466) |
| 17.5 |
52.5 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 16.2 |
227.4 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 12.3 |
36.9 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 12.2 |
36.6 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 12.0 |
48.2 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 10.6 |
31.8 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 9.7 |
29.0 |
GO:0046959 |
habituation(GO:0046959) |
| 9.5 |
19.0 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 9.3 |
37.2 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 9.1 |
63.9 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 8.7 |
35.0 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 8.2 |
32.9 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 7.9 |
39.4 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 7.7 |
23.0 |
GO:1901254 |
positive regulation of intracellular transport of viral material(GO:1901254) |
| 7.0 |
35.2 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 6.9 |
27.6 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 6.9 |
34.4 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 6.7 |
6.7 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 6.6 |
19.7 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
| 6.5 |
26.2 |
GO:0021586 |
pons maturation(GO:0021586) |
| 6.4 |
102.1 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 6.3 |
100.9 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 5.9 |
5.9 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 5.9 |
17.6 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 5.8 |
52.4 |
GO:0033602 |
negative regulation of dopamine secretion(GO:0033602) |
| 5.8 |
34.6 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 5.7 |
17.2 |
GO:0021830 |
substrate-independent telencephalic tangential migration(GO:0021826) interneuron migration from the subpallium to the cortex(GO:0021830) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 5.6 |
16.8 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 5.5 |
16.5 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 5.5 |
27.3 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 5.4 |
48.3 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 5.3 |
16.0 |
GO:0045924 |
regulation of female receptivity(GO:0045924) |
| 5.3 |
21.0 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 5.2 |
15.7 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 5.2 |
41.7 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 5.2 |
5.2 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 5.2 |
20.6 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 5.1 |
15.2 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 5.0 |
15.1 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 5.0 |
20.0 |
GO:0021882 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
| 4.9 |
4.9 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 4.9 |
24.5 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 4.7 |
23.7 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 4.6 |
13.7 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 4.5 |
13.5 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 4.5 |
4.5 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 4.4 |
17.6 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 4.4 |
13.1 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 4.3 |
8.7 |
GO:1900453 |
negative regulation of long term synaptic depression(GO:1900453) |
| 4.3 |
21.5 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 4.3 |
17.2 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 4.3 |
12.8 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 4.1 |
53.8 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 4.1 |
12.4 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 4.1 |
20.6 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 4.1 |
12.3 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 4.1 |
12.2 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 4.1 |
20.4 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 4.1 |
4.1 |
GO:0003025 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 4.0 |
4.0 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 4.0 |
40.1 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 4.0 |
91.2 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 3.9 |
67.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 3.9 |
19.7 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 3.9 |
3.9 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 3.9 |
113.4 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 3.8 |
3.8 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 3.8 |
22.7 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 3.7 |
22.4 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 3.7 |
29.6 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 3.7 |
11.1 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 3.6 |
7.2 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 3.6 |
7.2 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 3.5 |
31.8 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 3.5 |
3.5 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 3.5 |
17.4 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 3.4 |
6.8 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 3.4 |
10.2 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
| 3.4 |
40.6 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 3.3 |
3.3 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 3.3 |
36.5 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 3.3 |
13.2 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 3.3 |
9.9 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 3.3 |
29.5 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 3.3 |
3.3 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 3.3 |
13.1 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 3.3 |
3.3 |
GO:0071372 |
response to follicle-stimulating hormone(GO:0032354) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 3.2 |
3.2 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 3.1 |
9.4 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 3.1 |
22.0 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 3.1 |
25.0 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 3.1 |
12.3 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 3.1 |
12.3 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 3.1 |
3.1 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 3.0 |
12.1 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 3.0 |
12.1 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 3.0 |
12.0 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 3.0 |
27.0 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 3.0 |
14.9 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 2.9 |
8.8 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 2.9 |
20.4 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 2.9 |
29.0 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 2.9 |
26.0 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 2.9 |
14.3 |
GO:0030242 |
pexophagy(GO:0030242) |
| 2.8 |
8.4 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 2.8 |
11.1 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 2.8 |
5.5 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 2.8 |
11.1 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 2.8 |
8.3 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 2.7 |
8.2 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 2.7 |
21.9 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 2.7 |
5.4 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 2.7 |
10.8 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 2.7 |
26.9 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 2.7 |
26.9 |
GO:0071435 |
potassium ion export(GO:0071435) |
| 2.7 |
5.4 |
GO:0090325 |
regulation of locomotion involved in locomotory behavior(GO:0090325) negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 2.7 |
10.8 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 2.7 |
21.5 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 2.7 |
8.0 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 2.7 |
16.0 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 2.7 |
13.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 2.7 |
10.6 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 2.6 |
28.8 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 2.6 |
13.0 |
GO:0034183 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 2.6 |
7.7 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 2.6 |
12.9 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 2.5 |
12.7 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 2.5 |
17.8 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 2.5 |
12.7 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 2.5 |
2.5 |
GO:0021764 |
amygdala development(GO:0021764) |
| 2.5 |
12.5 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 2.5 |
2.5 |
GO:0036482 |
neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 2.5 |
12.3 |
GO:1902669 |
positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
| 2.5 |
2.5 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 2.4 |
7.3 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 2.4 |
7.3 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 2.4 |
19.4 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 2.4 |
95.8 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 2.4 |
7.2 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 2.4 |
9.4 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 2.3 |
16.4 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 2.3 |
18.6 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 2.3 |
11.6 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 2.3 |
7.0 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 2.3 |
2.3 |
GO:0061324 |
canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) |
| 2.3 |
9.3 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 2.3 |
32.1 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 2.3 |
4.5 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 2.3 |
6.8 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 2.2 |
4.5 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 2.2 |
6.7 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) transepithelial ammonium transport(GO:0070634) |
| 2.2 |
8.9 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 2.2 |
28.7 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 2.2 |
19.9 |
GO:0044090 |
positive regulation of vacuole organization(GO:0044090) |
| 2.2 |
2.2 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 2.2 |
11.0 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 2.2 |
2.2 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 2.2 |
43.9 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 2.2 |
4.3 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 2.1 |
40.3 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 2.1 |
2.1 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 2.1 |
2.1 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 2.1 |
27.0 |
GO:0001964 |
startle response(GO:0001964) |
| 2.1 |
6.2 |
GO:2001258 |
negative regulation of cation channel activity(GO:2001258) |
| 2.1 |
8.2 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 2.1 |
47.3 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 2.1 |
12.3 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 2.1 |
10.3 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 2.0 |
12.2 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 2.0 |
16.1 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 2.0 |
12.1 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 2.0 |
6.0 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 2.0 |
6.0 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 2.0 |
54.2 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 2.0 |
8.0 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 2.0 |
8.0 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 2.0 |
18.0 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 2.0 |
5.9 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 2.0 |
7.9 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 2.0 |
17.7 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) |
| 2.0 |
23.5 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 1.9 |
5.8 |
GO:1905206 |
positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 1.9 |
34.8 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 1.9 |
3.9 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 1.9 |
11.6 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 1.9 |
3.8 |
GO:0010511 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 1.9 |
7.6 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 1.9 |
3.8 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 1.9 |
22.5 |
GO:0008038 |
neuron recognition(GO:0008038) |
| 1.9 |
7.5 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 1.9 |
1.9 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 1.9 |
5.6 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 1.8 |
5.5 |
GO:0008228 |
opsonization(GO:0008228) |
| 1.8 |
5.5 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 1.8 |
5.5 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.8 |
3.6 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 1.8 |
5.4 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 1.8 |
21.4 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 1.8 |
14.3 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 1.8 |
1.8 |
GO:0021604 |
cranial nerve structural organization(GO:0021604) |
| 1.8 |
10.6 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 1.8 |
3.5 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 1.8 |
8.8 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 1.7 |
5.2 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) protein myristoylation(GO:0018377) |
| 1.7 |
10.4 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 1.7 |
22.5 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 1.7 |
5.1 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 1.7 |
17.1 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 1.7 |
1.7 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 1.7 |
6.8 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 1.7 |
6.8 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 1.7 |
10.1 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 1.7 |
11.7 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 1.7 |
20.1 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 1.7 |
18.3 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 1.7 |
9.9 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 1.7 |
21.5 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 1.6 |
8.2 |
GO:0002692 |
negative regulation of cellular extravasation(GO:0002692) |
| 1.6 |
9.9 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 1.6 |
8.2 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 1.6 |
6.5 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 1.6 |
6.5 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 1.6 |
1.6 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 1.6 |
8.1 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 1.6 |
4.9 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 1.6 |
3.2 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.6 |
6.4 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 1.6 |
6.4 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 1.6 |
12.7 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 1.6 |
6.3 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 1.6 |
1.6 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 1.6 |
4.7 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.6 |
3.2 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 1.6 |
4.7 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 1.6 |
6.2 |
GO:0072197 |
ureter morphogenesis(GO:0072197) |
| 1.6 |
21.7 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 1.5 |
1.5 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 1.5 |
6.2 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 1.5 |
7.7 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 1.5 |
7.7 |
GO:0015871 |
choline transport(GO:0015871) |
| 1.5 |
4.6 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 1.5 |
4.6 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 1.5 |
7.7 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 1.5 |
6.1 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 1.5 |
1.5 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 1.5 |
15.3 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 1.5 |
4.6 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 1.5 |
4.5 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 1.5 |
3.0 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 1.5 |
1.5 |
GO:0072223 |
metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 1.5 |
7.5 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 1.5 |
3.0 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 1.5 |
4.4 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 1.5 |
17.6 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 1.5 |
10.3 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 1.5 |
5.8 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 1.4 |
5.8 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 1.4 |
14.4 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 1.4 |
7.2 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 1.4 |
15.8 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 1.4 |
1.4 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 1.4 |
5.7 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 1.4 |
9.9 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 1.4 |
19.7 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 1.4 |
7.0 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 1.4 |
50.5 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 1.4 |
4.1 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 1.4 |
4.1 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 1.4 |
15.2 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 1.4 |
11.0 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 1.4 |
4.1 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) serine phosphorylation of STAT protein(GO:0042501) |
| 1.4 |
8.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.3 |
5.4 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 1.3 |
4.0 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.3 |
6.7 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 1.3 |
4.0 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 1.3 |
1.3 |
GO:0003383 |
apical constriction(GO:0003383) |
| 1.3 |
4.0 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 1.3 |
6.6 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 1.3 |
9.2 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 1.3 |
3.9 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.3 |
12.9 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 1.3 |
6.4 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 1.3 |
19.2 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 1.3 |
50.5 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 1.3 |
11.4 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 1.2 |
23.7 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 1.2 |
5.0 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 1.2 |
3.7 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 1.2 |
34.7 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 1.2 |
3.7 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 1.2 |
3.7 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 1.2 |
12.2 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 1.2 |
9.7 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 1.2 |
4.8 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 1.2 |
10.9 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 1.2 |
1.2 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 1.2 |
3.6 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 1.2 |
5.9 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 1.2 |
2.4 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 1.2 |
4.7 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 1.2 |
2.4 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 1.2 |
2.4 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 1.2 |
10.6 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 1.2 |
11.6 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 1.2 |
5.8 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 1.2 |
1.2 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 1.2 |
2.3 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 1.1 |
29.8 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 1.1 |
5.7 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 1.1 |
2.3 |
GO:0043369 |
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
| 1.1 |
13.7 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 1.1 |
3.4 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.1 |
3.4 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 1.1 |
1.1 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 1.1 |
2.2 |
GO:0018197 |
peptidyl-aspartic acid modification(GO:0018197) |
| 1.1 |
43.6 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) |
| 1.1 |
1.1 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 1.1 |
3.3 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 1.1 |
3.3 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 1.1 |
2.2 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 1.1 |
4.4 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 1.1 |
7.7 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 1.1 |
28.4 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 1.1 |
7.6 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 1.1 |
1.1 |
GO:0035993 |
deltoid tuberosity development(GO:0035993) |
| 1.1 |
1.1 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 1.1 |
3.2 |
GO:0001828 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 1.1 |
2.1 |
GO:0045713 |
low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 1.1 |
1.1 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 1.1 |
1.1 |
GO:0045988 |
negative regulation of striated muscle contraction(GO:0045988) |
| 1.1 |
2.1 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 1.0 |
6.3 |
GO:0086026 |
atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
| 1.0 |
34.6 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 1.0 |
4.1 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 1.0 |
11.3 |
GO:0007616 |
long-term memory(GO:0007616) |
| 1.0 |
51.5 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 1.0 |
2.1 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 1.0 |
34.9 |
GO:0014044 |
Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 1.0 |
4.1 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 1.0 |
3.1 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 1.0 |
8.1 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 1.0 |
10.1 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 1.0 |
5.0 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 1.0 |
2.0 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 1.0 |
6.0 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 1.0 |
1.0 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 1.0 |
1.0 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 1.0 |
7.0 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 1.0 |
2.0 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 1.0 |
5.0 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 1.0 |
3.0 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 1.0 |
3.0 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 1.0 |
5.9 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 1.0 |
9.8 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 1.0 |
7.8 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 1.0 |
1.9 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 1.0 |
2.9 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 1.0 |
6.8 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 1.0 |
2.9 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 1.0 |
6.7 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 1.0 |
6.7 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 1.0 |
3.8 |
GO:0033003 |
regulation of mast cell activation(GO:0033003) |
| 1.0 |
10.5 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 1.0 |
2.9 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 1.0 |
4.8 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.9 |
7.5 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.9 |
1.9 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.9 |
5.6 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.9 |
2.8 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.9 |
13.1 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.9 |
2.8 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 0.9 |
2.8 |
GO:0070857 |
regulation of bile acid biosynthetic process(GO:0070857) |
| 0.9 |
2.8 |
GO:0072578 |
neurotransmitter-gated ion channel clustering(GO:0072578) |
| 0.9 |
2.8 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.9 |
0.9 |
GO:2000544 |
cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.9 |
3.7 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.9 |
34.5 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.9 |
3.6 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.9 |
7.2 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.9 |
32.5 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.9 |
1.8 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.9 |
3.6 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.9 |
8.1 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.9 |
4.5 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.9 |
0.9 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 0.9 |
4.4 |
GO:0035729 |
response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.9 |
2.7 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.9 |
0.9 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.9 |
9.7 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.9 |
7.8 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.9 |
6.1 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.9 |
10.4 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.9 |
0.9 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.9 |
2.6 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.9 |
2.6 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.9 |
1.7 |
GO:0071442 |
regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.9 |
1.7 |
GO:0031113 |
regulation of microtubule polymerization(GO:0031113) |
| 0.8 |
2.5 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.8 |
27.2 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.8 |
1.7 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.8 |
11.9 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.8 |
15.2 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.8 |
0.8 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.8 |
3.4 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.8 |
1.7 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.8 |
2.5 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.8 |
5.8 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.8 |
1.7 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.8 |
7.4 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.8 |
0.8 |
GO:0010616 |
negative regulation of cardiac muscle adaptation(GO:0010616) |
| 0.8 |
18.0 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.8 |
7.4 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.8 |
1.6 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.8 |
1.6 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.8 |
1.6 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.8 |
3.3 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.8 |
6.4 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.8 |
4.0 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.8 |
0.8 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.8 |
1.6 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.8 |
10.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.8 |
5.5 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.8 |
3.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.8 |
2.3 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.8 |
6.1 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.8 |
16.7 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.8 |
9.1 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.8 |
9.0 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.8 |
89.4 |
GO:0071804 |
cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.7 |
6.0 |
GO:1901621 |
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.7 |
6.0 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.7 |
4.5 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.7 |
10.4 |
GO:0060997 |
dendritic spine morphogenesis(GO:0060997) |
| 0.7 |
6.7 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.7 |
2.9 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.7 |
6.6 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.7 |
2.9 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.7 |
0.7 |
GO:1904884 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.7 |
9.5 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.7 |
3.6 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.7 |
1.4 |
GO:0010869 |
regulation of receptor biosynthetic process(GO:0010869) |
| 0.7 |
1.4 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.7 |
0.7 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.7 |
2.2 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.7 |
2.2 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.7 |
0.7 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.7 |
2.9 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.7 |
15.7 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.7 |
2.1 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.7 |
3.5 |
GO:0060998 |
regulation of dendritic spine development(GO:0060998) |
| 0.7 |
0.7 |
GO:0060306 |
regulation of membrane repolarization(GO:0060306) |
| 0.7 |
4.9 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.7 |
4.2 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.7 |
2.8 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.7 |
0.7 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.7 |
5.6 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.7 |
4.9 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) |
| 0.7 |
4.9 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.7 |
0.7 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.7 |
2.1 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.7 |
3.4 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.7 |
4.1 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.7 |
4.1 |
GO:0002328 |
pro-B cell differentiation(GO:0002328) |
| 0.7 |
2.7 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.7 |
4.1 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.7 |
4.7 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.7 |
3.4 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.7 |
2.0 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.7 |
2.0 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.7 |
10.0 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.7 |
2.7 |
GO:0014889 |
muscle atrophy(GO:0014889) |
| 0.7 |
9.9 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.7 |
3.3 |
GO:0021895 |
cerebral cortex neuron differentiation(GO:0021895) |
| 0.7 |
3.3 |
GO:0098597 |
observational learning(GO:0098597) |
| 0.7 |
5.2 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.6 |
1.9 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.6 |
1.3 |
GO:1903044 |
protein localization to membrane raft(GO:1903044) |
| 0.6 |
0.6 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.6 |
0.6 |
GO:0033129 |
positive regulation of histone phosphorylation(GO:0033129) |
| 0.6 |
0.6 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.6 |
1.2 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 0.6 |
1.8 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.6 |
0.6 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.6 |
3.7 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.6 |
2.5 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.6 |
82.1 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.6 |
7.9 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.6 |
1.8 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.6 |
3.0 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.6 |
3.0 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.6 |
1.2 |
GO:0010954 |
positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
| 0.6 |
1.2 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.6 |
4.2 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.6 |
6.5 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.6 |
0.6 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.6 |
3.0 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.6 |
0.6 |
GO:1902837 |
amino acid import into cell(GO:1902837) |
| 0.6 |
2.9 |
GO:1904181 |
positive regulation of membrane depolarization(GO:1904181) |
| 0.6 |
1.2 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 0.6 |
7.0 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.6 |
3.5 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.6 |
4.7 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.6 |
0.6 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.6 |
2.3 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.6 |
5.7 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.6 |
2.9 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.6 |
1.7 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.6 |
1.7 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.6 |
0.6 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.6 |
1.1 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.6 |
2.8 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.6 |
1.7 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.6 |
3.4 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.6 |
7.3 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.6 |
2.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.6 |
6.7 |
GO:0002446 |
neutrophil mediated immunity(GO:0002446) |
| 0.6 |
1.7 |
GO:0032725 |
positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
| 0.6 |
1.1 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.5 |
3.8 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.5 |
11.4 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.5 |
2.7 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.5 |
37.0 |
GO:0006836 |
neurotransmitter transport(GO:0006836) |
| 0.5 |
4.8 |
GO:0010803 |
regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.5 |
1.1 |
GO:0032096 |
negative regulation of response to food(GO:0032096) regulation of appetite(GO:0032098) negative regulation of appetite(GO:0032099) |
| 0.5 |
0.5 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.5 |
4.2 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.5 |
1.6 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.5 |
1.6 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.5 |
5.7 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.5 |
5.7 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.5 |
1.5 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.5 |
2.1 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.5 |
1.0 |
GO:2000427 |
regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.5 |
1.5 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.5 |
3.6 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.5 |
0.5 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.5 |
1.5 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.5 |
3.6 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.5 |
22.4 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
| 0.5 |
1.5 |
GO:0060468 |
prevention of polyspermy(GO:0060468) |
| 0.5 |
2.5 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.5 |
3.0 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.5 |
24.2 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.5 |
7.6 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.5 |
3.5 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.5 |
2.0 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.5 |
1.5 |
GO:0060253 |
negative regulation of glial cell proliferation(GO:0060253) |
| 0.5 |
0.5 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.5 |
0.5 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.5 |
1.5 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.5 |
0.5 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.5 |
27.4 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.5 |
1.4 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.5 |
1.4 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.5 |
2.8 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.5 |
1.4 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.5 |
0.9 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.5 |
1.9 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.5 |
8.4 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.5 |
0.9 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.5 |
0.5 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.5 |
0.5 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.5 |
1.8 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.5 |
8.6 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.5 |
2.3 |
GO:0010544 |
negative regulation of platelet activation(GO:0010544) negative regulation of platelet aggregation(GO:0090331) |
| 0.5 |
1.8 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.4 |
3.1 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.4 |
2.7 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.4 |
0.9 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.4 |
1.3 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.4 |
1.8 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.4 |
2.6 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.4 |
2.6 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.4 |
2.2 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.4 |
0.9 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.4 |
0.9 |
GO:0071455 |
cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
| 0.4 |
1.7 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.4 |
6.7 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.4 |
1.3 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) |
| 0.4 |
2.9 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.4 |
1.3 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.4 |
1.2 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.4 |
2.1 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.4 |
1.6 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.4 |
2.5 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.4 |
1.6 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.4 |
0.8 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.4 |
1.2 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.4 |
3.6 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.4 |
2.0 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.4 |
0.4 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.4 |
10.8 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.4 |
0.4 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.4 |
0.4 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.4 |
10.3 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.4 |
0.4 |
GO:0032800 |
receptor biosynthetic process(GO:0032800) |
| 0.4 |
0.8 |
GO:0086001 |
cardiac muscle cell action potential(GO:0086001) |
| 0.4 |
2.8 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.4 |
1.6 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.4 |
3.2 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.4 |
0.4 |
GO:0061141 |
lung ciliated cell differentiation(GO:0061141) |
| 0.4 |
1.6 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.4 |
1.2 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.4 |
0.8 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.4 |
1.2 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.4 |
2.4 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.4 |
1.2 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.4 |
1.9 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.4 |
4.2 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.4 |
9.1 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.4 |
2.6 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.4 |
6.0 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.4 |
1.1 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.4 |
0.4 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.4 |
0.7 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.4 |
1.1 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.4 |
1.5 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.4 |
2.9 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.4 |
0.7 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.4 |
1.1 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.4 |
5.3 |
GO:0007270 |
neuron-neuron synaptic transmission(GO:0007270) |
| 0.4 |
1.8 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.4 |
5.6 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.3 |
1.4 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.3 |
0.7 |
GO:0032743 |
positive regulation of interleukin-2 production(GO:0032743) |
| 0.3 |
3.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.3 |
0.7 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.3 |
1.4 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.3 |
3.8 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.3 |
0.7 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.3 |
3.1 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.3 |
4.4 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.3 |
2.7 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.3 |
0.7 |
GO:0010820 |
regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 0.3 |
2.3 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.3 |
1.0 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.3 |
1.0 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.3 |
4.3 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) inositol phosphate-mediated signaling(GO:0048016) |
| 0.3 |
11.3 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.3 |
1.7 |
GO:0050716 |
regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.3 |
1.0 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.3 |
1.6 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.3 |
1.0 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.3 |
1.3 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.3 |
4.2 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.3 |
7.5 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.3 |
1.0 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.3 |
2.9 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.3 |
1.9 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.3 |
1.0 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.3 |
5.1 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.3 |
0.6 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.3 |
1.3 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.3 |
8.0 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.3 |
0.9 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.3 |
0.6 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.3 |
2.7 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.3 |
1.5 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.3 |
6.7 |
GO:0048008 |
platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.3 |
7.0 |
GO:0007595 |
lactation(GO:0007595) |
| 0.3 |
0.9 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.3 |
3.9 |
GO:0098930 |
axonal transport(GO:0098930) |
| 0.3 |
0.6 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.3 |
0.9 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.3 |
0.9 |
GO:0006688 |
glycosphingolipid biosynthetic process(GO:0006688) |
| 0.3 |
1.2 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.3 |
2.0 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.3 |
1.2 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.3 |
0.9 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.3 |
1.2 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.3 |
2.3 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.3 |
0.3 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 |
0.3 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.3 |
2.0 |
GO:0009188 |
ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.3 |
3.1 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.3 |
2.8 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.3 |
1.1 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.3 |
0.8 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.3 |
1.4 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 |
1.4 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.3 |
1.4 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.3 |
0.8 |
GO:0036508 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.3 |
1.3 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.3 |
2.7 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.3 |
0.8 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.3 |
0.8 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.3 |
0.8 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 0.3 |
2.1 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.3 |
0.8 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.3 |
1.0 |
GO:0032788 |
saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.3 |
0.3 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.3 |
1.5 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.3 |
2.3 |
GO:0042130 |
negative regulation of T cell proliferation(GO:0042130) |
| 0.3 |
2.0 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.3 |
1.3 |
GO:1901655 |
cellular response to ketone(GO:1901655) |
| 0.3 |
1.3 |
GO:0050687 |
negative regulation of defense response to virus(GO:0050687) |
| 0.3 |
0.5 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.3 |
4.8 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.3 |
1.3 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.3 |
0.5 |
GO:0051788 |
response to misfolded protein(GO:0051788) |
| 0.2 |
0.7 |
GO:0090169 |
regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
| 0.2 |
3.0 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.2 |
0.5 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 0.2 |
0.5 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.2 |
2.0 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.2 |
2.2 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 |
1.4 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
5.0 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.2 |
1.7 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.2 |
4.0 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.2 |
7.2 |
GO:0007612 |
learning(GO:0007612) |
| 0.2 |
0.2 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.2 |
6.5 |
GO:0050729 |
positive regulation of inflammatory response(GO:0050729) |
| 0.2 |
1.2 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.2 |
0.2 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.2 |
0.5 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.2 |
0.9 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 0.2 |
7.7 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.2 |
0.5 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.2 |
1.8 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.2 |
1.1 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
0.9 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 |
0.7 |
GO:0045072 |
regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 |
1.5 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.2 |
0.4 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.2 |
4.1 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 |
2.6 |
GO:0033866 |
nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.2 |
0.9 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.2 |
1.1 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.2 |
2.1 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.2 |
1.9 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 |
0.4 |
GO:0032727 |
positive regulation of interferon-alpha production(GO:0032727) |
| 0.2 |
0.6 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.2 |
1.6 |
GO:0070861 |
regulation of protein exit from endoplasmic reticulum(GO:0070861) |
| 0.2 |
1.8 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.2 |
2.0 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 |
0.8 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 |
3.0 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.2 |
1.2 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.2 |
0.4 |
GO:0009838 |
abscission(GO:0009838) |
| 0.2 |
0.6 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.2 |
0.6 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 |
0.6 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.2 |
1.9 |
GO:0021696 |
cerebellar cortex morphogenesis(GO:0021696) |
| 0.2 |
1.0 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.2 |
5.2 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.2 |
0.9 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.2 |
0.9 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.2 |
0.2 |
GO:0032278 |
positive regulation of gonadotropin secretion(GO:0032278) |
| 0.2 |
0.7 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 |
0.9 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.2 |
0.2 |
GO:0045346 |
regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.2 |
0.4 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.2 |
1.5 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.2 |
3.8 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.2 |
0.7 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 |
0.4 |
GO:1990542 |
mitochondrial transmembrane transport(GO:1990542) |
| 0.2 |
8.9 |
GO:0036503 |
ERAD pathway(GO:0036503) |
| 0.2 |
0.7 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.2 |
1.0 |
GO:0042755 |
eating behavior(GO:0042755) |
| 0.2 |
2.3 |
GO:0051668 |
localization within membrane(GO:0051668) |
| 0.2 |
0.7 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.2 |
0.5 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.2 |
0.7 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.2 |
0.6 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 |
20.4 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
| 0.2 |
0.2 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.2 |
1.3 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.2 |
1.1 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.2 |
0.8 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.2 |
0.9 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.2 |
1.1 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.2 |
3.8 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.2 |
0.6 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 |
11.0 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.2 |
1.4 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.1 |
0.6 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 |
1.6 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 |
6.5 |
GO:0006906 |
vesicle fusion(GO:0006906) |
| 0.1 |
0.4 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.4 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 |
0.6 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.1 |
0.3 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
1.0 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.7 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
| 0.1 |
0.3 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
0.5 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.3 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.1 |
1.1 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.1 |
1.6 |
GO:0097300 |
programmed necrotic cell death(GO:0097300) |
| 0.1 |
0.4 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.1 |
0.9 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.5 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.1 |
0.6 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.1 |
0.6 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
1.1 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.6 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 |
0.7 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.1 |
7.5 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.1 |
0.8 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.2 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.1 |
2.5 |
GO:0006821 |
chloride transport(GO:0006821) |
| 0.1 |
0.7 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.1 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.1 |
0.5 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.1 |
1.7 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.1 |
2.9 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.1 |
1.4 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.1 |
0.4 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 |
0.3 |
GO:2000619 |
negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.1 |
0.6 |
GO:0009109 |
coenzyme catabolic process(GO:0009109) |
| 0.1 |
0.3 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
1.3 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.1 |
0.2 |
GO:0042891 |
antibiotic transport(GO:0042891) |
| 0.1 |
1.7 |
GO:1901216 |
positive regulation of neuron death(GO:1901216) |
| 0.1 |
0.8 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.3 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.2 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.1 |
0.4 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
0.2 |
GO:0072676 |
lymphocyte migration(GO:0072676) regulation of lymphocyte migration(GO:2000401) |
| 0.1 |
0.6 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
1.0 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
1.7 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
0.3 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 |
0.4 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) cytosol to ER transport(GO:0046967) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
1.0 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.1 |
0.1 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 0.1 |
0.1 |
GO:0090179 |
planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.1 |
0.2 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.4 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.1 |
1.1 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.1 |
1.2 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.1 |
0.1 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.1 |
0.3 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.4 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 |
0.2 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.1 |
0.6 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 |
0.8 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.1 |
1.8 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 |
0.2 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.1 |
GO:0032660 |
regulation of interleukin-17 production(GO:0032660) |
| 0.1 |
0.2 |
GO:0070664 |
negative regulation of leukocyte proliferation(GO:0070664) |
| 0.1 |
0.2 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
0.1 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.1 |
0.4 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.4 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
0.4 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
0.2 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.0 |
0.2 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.0 |
0.2 |
GO:0006547 |
histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
| 0.0 |
0.2 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 |
0.0 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 0.0 |
0.1 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.4 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.0 |
1.9 |
GO:0006497 |
protein lipidation(GO:0006497) |
| 0.0 |
0.0 |
GO:0042518 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
| 0.0 |
0.3 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.0 |
1.5 |
GO:0007338 |
single fertilization(GO:0007338) |
| 0.0 |
0.5 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.0 |
0.2 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.2 |
GO:0042402 |
cellular biogenic amine catabolic process(GO:0042402) |
| 0.0 |
0.0 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
| 0.0 |
0.3 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 |
0.2 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 |
0.1 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.0 |
0.2 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.2 |
GO:0046070 |
dGTP metabolic process(GO:0046070) |
| 0.0 |
0.4 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.0 |
0.2 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.0 |
0.1 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.0 |
0.1 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 |
0.6 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.0 |
0.1 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.2 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.0 |
GO:0051531 |
NFAT protein import into nucleus(GO:0051531) |
| 0.0 |
0.0 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 |
0.3 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.0 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.0 |
0.2 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
0.0 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.0 |
0.1 |
GO:0051189 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 |
0.1 |
GO:0002192 |
IRES-dependent translational initiation(GO:0002192) |
| 0.0 |
0.6 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.2 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
0.0 |
GO:0061046 |
regulation of branching involved in lung morphogenesis(GO:0061046) |
| 0.0 |
0.1 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.0 |
0.1 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.0 |
0.1 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.0 |
0.0 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.0 |
0.0 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.0 |
0.1 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
